Kiyoshi Takasuna

1.5k total citations
56 papers, 1.2k citations indexed

About

Kiyoshi Takasuna is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kiyoshi Takasuna has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kiyoshi Takasuna's work include Cardiac electrophysiology and arrhythmias (17 papers), Ion channel regulation and function (13 papers) and Receptor Mechanisms and Signaling (9 papers). Kiyoshi Takasuna is often cited by papers focused on Cardiac electrophysiology and arrhythmias (17 papers), Ion channel regulation and function (13 papers) and Receptor Mechanisms and Signaling (9 papers). Kiyoshi Takasuna collaborates with scholars based in Japan, Germany and Sweden. Kiyoshi Takasuna's co-authors include Masaaki Hirohashi, Mamoru Nomura, Takehiro Hagiwara, Yutaka Kitano, Eiichi Nagai, Tsuyoshi Yokoi, Michiyuki Kato, Tetsuya Kamataki, Mitsuhiro Makino and Kazuhiko Mori and has published in prestigious journals such as Scientific Reports, Brain Research and British Journal of Pharmacology.

In The Last Decade

Kiyoshi Takasuna

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyoshi Takasuna Japan 19 697 382 204 167 148 56 1.2k
Giorgio Annoni Italy 21 503 0.7× 108 0.3× 65 0.3× 129 0.8× 61 0.4× 43 1.8k
Fruzsina R. Walter Hungary 25 511 0.7× 352 0.9× 251 1.2× 28 0.2× 67 0.5× 58 1.9k
Shuo Li China 20 597 0.9× 129 0.3× 93 0.5× 77 0.5× 76 0.5× 109 1.4k
Ya-Ching Hsieh United States 23 610 0.9× 128 0.3× 184 0.9× 60 0.4× 106 0.7× 27 1.7k
Masaaki Hirohashi Japan 12 491 0.7× 350 0.9× 75 0.4× 20 0.1× 147 1.0× 33 839
Meng Sun China 19 565 0.8× 74 0.2× 151 0.7× 47 0.3× 74 0.5× 49 1.3k
Yoshiharu Itoh Japan 20 757 1.1× 57 0.1× 180 0.9× 216 1.3× 74 0.5× 56 1.6k
Anikó Somogyi Hungary 22 385 0.6× 179 0.5× 84 0.4× 120 0.7× 79 0.5× 133 1.8k
Jing Yu China 23 782 1.1× 123 0.3× 181 0.9× 106 0.6× 115 0.8× 66 1.6k

Countries citing papers authored by Kiyoshi Takasuna

Since Specialization
Citations

This map shows the geographic impact of Kiyoshi Takasuna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Takasuna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Takasuna more than expected).

Fields of papers citing papers by Kiyoshi Takasuna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoshi Takasuna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Takasuna. The network helps show where Kiyoshi Takasuna may publish in the future.

Co-authorship network of co-authors of Kiyoshi Takasuna

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoshi Takasuna. A scholar is included among the top collaborators of Kiyoshi Takasuna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoshi Takasuna. Kiyoshi Takasuna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takasuna, Kiyoshi, et al.. (2019). Comprehensive Cardiac Safety Assessment using hiPS-cardiomyocytes (Consortium for Safety Assessment using Human iPS Cells: CSAHi). Current Pharmaceutical Biotechnology. 21(9). 829–841. 7 indexed citations
2.
Hattori, Akihiro, Kenji Matsuura, Fumimasa Nomura, et al.. (2018). On-chip spatiotemporal electrophysiological analysis of human stem cell derived cardiomyocytes enables quantitative assessment of proarrhythmia in drug development. Scientific Reports. 8(1). 14536–14536. 16 indexed citations
3.
Nomura, Fumimasa, et al.. (2018). Electrophysiological evaluation of pentamidine and 17-AAG in human stem cell-derived cardiomyocytes for safety assessment. European Journal of Pharmacology. 842. 221–230. 11 indexed citations
4.
Sasaki, Akira, et al.. (2014). Comparison of Renal Biomarkers with Glomerular Filtration Rate in Susceptibility to the Detection of Gentamicin-Induced Acute Kidney Injury in Dogs. Journal of Comparative Pathology. 151(2-3). 264–270. 25 indexed citations
5.
Kaneko, Tomoyuki, Fumimasa Nomura, Yasuyuki Abe, et al.. (2014). On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip. Scientific Reports. 4(1). 4670–4670. 35 indexed citations
6.
Nakamura, Yuji, Teppei Fujimoto, Yasuyuki Ogawa, et al.. (2013). Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: Discovery of DS-8108b, an orally active renin inhibitor. Bioorganic & Medicinal Chemistry. 21(11). 3175–3196. 11 indexed citations
7.
Chiba, Katsuyoshi, Atsushi Sugiyama, Kazuo Watanabe, Kiyoshi Takasuna, & Keitaro Hashimoto. (2006). Acute Hypokalemia May Not Be an Effective Way to Sensitize the In Situ Canine Heart for Sparfloxacin-Induced Long QT Syndrome. Journal of Pharmacological Sciences. 100(1). 88–92. 3 indexed citations
8.
Kitano, Yutaka, Mitsuhiro Makino, Kiyoshi Takasuna, et al.. (2005). Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats. Brain Research. 1057(1-2). 168–176. 16 indexed citations
9.
Chiba, Katsuyoshi, Atsushi Sugiyama, Takehiro Hagiwara, et al.. (2004). In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome. European Journal of Pharmacology. 486(2). 189–200. 36 indexed citations
10.
Shinkai, Norihiro, Kiyoshi Takasuna, & Satoshi Takayama. (2003). Inhibitory effects of formoterol on lipopolysaccharide-induced premature delivery through modulation of proinflammatory cytokine production in mice. Reproduction. 125(2). 199–203. 8 indexed citations
11.
Hagiwara, Toshihiko, et al.. (2001). Toxicity/tolerability (Abstracts P129-P136). Journal of Antimicrobial Chemotherapy. 47(suppl_2). 49–50. 1 indexed citations
12.
Mori, Kazuhiko, et al.. (2001). Differential response of mast cells separated from various organs and basophils of dogs to the fluoroquinolone antimicrobial levofloxacin. Archives of Toxicology. 75(4). 227–233. 3 indexed citations
13.
Hagiwara, Takehiro, et al.. (2001). A Comparative Study of the Fluoroquinolone Antibacterial Agents on the Action Potential Duration in Guinea Pig Ventricular Myocardia.. The Japanese Journal of Pharmacology. 87(3). 231–234. 27 indexed citations
14.
Makino, Mitsuhiro, et al.. (2000). Human interferon-α induces immobility in the mouse forced swimming test: involvement of the opioid system. Brain Research. 852(2). 482–484. 29 indexed citations
15.
Makino, Mitsuhiro, et al.. (2000). Involvement of central opioid systems in human interferon‐α induced immobility in the mouse forced swimming test. British Journal of Pharmacology. 130(6). 1269–1274. 38 indexed citations
16.
Kitano, Yutaka, et al.. (1999). Anticonvulsant properties of the novel nootropic agent nefiracetam (DM-9384) on seizure models of mice.. Epilepsia. 40. 125. 5 indexed citations
17.
Makino, Mitsuhiro, et al.. (1997). Involvement of CNS opioid system in interferon-induced depression in mice. The Japanese Journal of Pharmacology. 73. 171–171. 2 indexed citations
18.
Takasuna, Kiyoshi, Yoshio Kasai, Yutaka Kitano, et al.. (1995). Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in Rats. Japanese Journal of Cancer Research. 86(10). 978–984. 85 indexed citations
19.
Takasuna, Kiyoshi, et al.. (1995). Study on the mechanisms of diarrhea induced by a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats.. Folia Pharmacologica Japonica. 105(6). 447–460. 31 indexed citations
20.
Kojima, H., et al.. (1988). General pharmacological properties of muroctasin.. PubMed. 38(7A). 1002–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgio Annoni Breakdown of academic impact, for papers by Fruzsina R. Walter Breakdown of academic impact, for papers by Shuo Li Breakdown of academic impact, for papers by Ya-Ching Hsieh Breakdown of academic impact, for papers by Masaaki Hirohashi Breakdown of academic impact, for papers by Meng Sun Breakdown of academic impact, for papers by Yoshiharu Itoh Breakdown of academic impact, for papers by Anikó Somogyi Breakdown of academic impact, for papers by Jing Yu
Rankless by CCL
2026